Page last updated: 2024-10-26

3,3'-diindolylmethane and Adenomatous Polyposis Coli

3,3'-diindolylmethane has been researched along with Adenomatous Polyposis Coli in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatnagar, N1
Li, X1
Chen, Y1
Zhou, X1
Garrett, SH1
Guo, B1

Other Studies

1 other study available for 3,3'-diindolylmethane and Adenomatous Polyposis Coli

ArticleYear
3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.
    Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:6

    Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Animals; Anticarcinogenic Agents; Apoptosis; Butyrates;

2009